First, we confirmed that a highly significant reduction of OVA-specific CD8 T cells was achieved only when active MEK-1 and IiOVA were simultaneously expressed from the same lentivector backbone, with a reduction from 500 spots per million splenocytes down to ∼40 spots per million splenocytes, as assessed by IFNγ ELISpot assay ( Figure 1A ).
← all excerpts
Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis.
1
—
—